Sequential Treatment With Targeted and Immune Checkpoint Therapy in Patients With BRAF Positive Metastatic Melanoma: The Importance of Timing?

Background: Immune checkpoint- and targeted therapy have dramatically improved the therapeutic landscape in the management of BRAF mutation positive metastatic melanoma. However, pending the results of clinical trials, not only is it currently unclear whether immune checkpoint- or targeted therapy s...

Descripción completa

Detalles Bibliográficos
Autores principales: Grätz, Victoria, Zillikens, Detlef, Busch, Hauke, Langan, Ewan A., Terheyden, Patrick
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6928141/
https://www.ncbi.nlm.nih.gov/pubmed/31921863
http://dx.doi.org/10.3389/fmed.2019.00257

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6928141/
https://www.ncbi.nlm.nih.gov/pubmed/31921863
http://dx.doi.org/10.3389/fmed.2019.00257

Ejemplares similares